Author:
McLoughlin Eavan C.,Twamley Brendan,O'Brien John E.,Hannon Barroeta Patricia,Zisterer Daniela M.,Meegan Mary J.,O'Boyle Niamh M.
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference97 articles.
1. β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells;Malebari;Eur. J. Med. Chem.,2020
2. β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells;Malebari;Eur. J. Med. Chem.,2017
3. ICH, ICH Topic Q 6 A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances In Q 6 A, EMA, Ed. EMA: London, 1999; Vol. CPMP/ICH/367/96) pp 2-32.
4. EMA, Investigation of Chiral Active Substances. In 3CC29a EMA, Ed. EMA: London, 1993; Vol. 75/318/EEC pp 381-391.
5. WHO Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer (accessed 7-2-22).